glp-1 supply manufacturing news today Drugmakers and CDMOs seize opportunity, invest in facilities GLP-1 Drugs from the Gray
Description
The Announcement: Prices Are Dropping Fast On Nov
Importantly, nearly 70% of participants in the semaglutide group lost at least 10% of their body weight, a threshold associated with meaningful improvements in cardiovascular and metabolic health markers
That third pathway matters
29% use apps to track activity and food
